98%
921
2 minutes
20
Injectable fillers represent one of the most requested minimally invasive treatments to rejuvenate the aging face, and its popularity is steadily rising. A vast majority of filler treatments are with hyaluronic acid (HA). The aim of this systematic review is to evaluate patient outcomes, safety profile, and administration techniques of various HA fillers for malar augmentation. A systematic review of the published literature was conducted in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines and included PubMed, Embase, and Science Direct databases. Medical Subject Headings (MeSH) terms used were "cheek" OR "midface" OR "malar" and "filler" OR "hyaluronic acid" OR "Juvederm" OR "Restylane" OR "Perlane" OR "Belotero." The initial search identified 699 articles; 256 duplicates were removed. Additional 12 studies were identified from reference lists. A total of 455 were screened by title and abstract and 387 studies were eliminated based on criteria. Also, 68 articles underwent full-text review, and 18 articles were included in the final review and involved seven different HA formulations. Men and women from many age groups were highly satisfied with their results following HA treatment for midface augmentation up to 24 months. The most common adverse events included bruising, swelling, and tenderness, and typically lasted no more than 2 weeks. Upper cheek filler injections near the zygoma should be placed in the submuscular plane while lower cheek injections should be placed in the subcutaneous tissue. HA is an attractive choice for midface augmentation due to its high patient satisfaction, long-lasting effects, and low side-effect profile. Due to the variability in technique, level of expertise, and subjective measurements across studies, one optimal regimen could not be concluded. However, midface augmentation treatment should be personalized to each patient. Additional clinical trials are required to more conclusively determine the most appropriate approach for this procedure.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1055/s-0041-1724122 | DOI Listing |
Plast Reconstr Surg
July 2025
Plastic and Reconstructive Surgery Unit, Department of Precision Medicine in Medical, Surgical and Critical Care, University of Palermo, 90127 Palermo, Italy.
Introduction: Malar region treatment is crucial for facial feminization in individuals assigned male at birth (AMAB). The main therapeutic options are malar implants and lipofilling, sometimes combined with injectable fillers. However, no consensus exists in the literature on the superiority of one technique over the other.
View Article and Find Full Text PDFBioinformation
April 2025
Department of Oral and Maxillofacial Surgery, DY Patil University School of Dentistry, Navi Mumbai, Maharashtra, India.
Mid-face volume loss is a common concern among ageing individuals, resulting in a hollow or sunken appearance. Hyaluronic acid (HA) dermal fillers have become a popular non-surgical solution to restore lost volume and enhance facial aesthetics. Therefore, it is of interest to assess the effect of various Hyaluronic acid (HA) fillers for mid-face augmentation.
View Article and Find Full Text PDFAesthetic Plast Surg
June 2025
Center for Plastic and Reconstructive Surgery, Department of Plastic and Reconstructive Surgery, Zhejiang Provincial People's Hospital(Affiliated People's Hospital), Hangzhou Medical College, 158# Shangtang Road, Hangzhou, Zhejiang, China.
Background: Anatomical differences in facial aging and aesthetic needs of Asian and Caucasian individuals have led to disparate clinical rejuvenation strategies using filler augmentation for midface volume deficits. Therefore, the Asian Midface Volume Deficit Severity Scale (AMVDSS) by LBTD (Lanzhou Biotechnique Development Co, Ltd) was developed to objectively assess midface volume deficits and clinical outcomes of Asian individuals.
Methods: Four observers independently rated randomized photographs (front, left and right 45°, left and right 90°) of 65 patients during two sessions with a 2-week interval using the AMVDSS.
Indian J Dent Res
June 2025
Department of Orthodontics and Dentofacial Orthopedics, Sri Ramachandra Dental College and Hospital, SRIHER (DU), Chennai, Tamil Nadu, India.
Skeletal Class III malocclusion in adolescents can be effectively managed using the combination of maxillary skeletal expander (MSE) and facemask (FM). An adolescent presented concerns about her lower front teeth positioned ahead of the upper front teeth, difficulty closing the lips, and dissatisfaction with the facial appearance. The patient exhibited a skeletal Class III profile, reverse overjet, a 2 mm overbite, concave facial profile, midface retrusion, mandibular prognathism, chin deviation to the right, and increased lower facial height (LFH).
View Article and Find Full Text PDFJ Cosmet Dermatol
June 2025
Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Korea.
Background: Calcium hydroxyapatite (CaHA) fillers are widely used for soft-tissue augmentation due to their volumizing properties and biostimulatory effects. However, clinical evidence supporting the dual role of CaHA as both a volumizer and a skin booster remains limited.
Objectives: To evaluate the efficacy of CaHA filler (VoLassom) in midface volume restoration and assess its effects on skin barrier function, hydration, and elasticity over 24 weeks.